Elon Musk's Neuralink gets U.S. FDA approval for human clinical study of brain implants

05/25/2023 | 06:36pm

(Reuters) - Elon Musk's brain-implant company Neuralink on Thursday said it received U.S. Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.

(Reporting by Akriti Sharma in Bengaluru; Editing by Anil D'Silva)

Reuters 2023
Copier lien
Latest news about Elon Musk
2d ago
3d ago
4d ago
5d ago
05/25